Skip to content

In EuroSIDA cohort 9% coinfected with HIV/HBV, but coinfected do just as well on HAART

HIV pharmacogenomics website launched

Drug-resistant HIV infections not rising in France

Mild neuropsychiatric disorders can persist for two years after starting efavirenz

Getting antiretrovirals to where they are needed

Extra £24 million of UK government funding for microbicide gel trial

Benefits of genotypic testing confirmed in French clinic study

Genetic differences predict triglyceride increase on ritonavir-boosted PI

UK sexual health services improving, but many clinics still struggling to cope